` KMDA (Kamada Ltd) vs S&P 500 Comparison - Alpha Spread

KMDA
vs
S&P 500

Over the past 12 months, KMDA has significantly outperformed S&P 500, delivering a return of 51% compared to the S&P 500's 9% growth.

Stocks Performance
KMDA vs S&P 500

Loading
KMDA
S&P 500
Add Stock

Performance Gap
KMDA vs S&P 500

Loading
KMDA
S&P 500
Difference
www.alphaspread.com

Performance By Year
KMDA vs S&P 500

Loading
KMDA
S&P 500
Add Stock

Competitors Performance
Kamada Ltd vs Peers

S&P 500
KMDA
ABBV
AMGN
GILD
VRTX
Add Stock

Kamada Ltd
Glance View

Market Cap
415.2m USD
Industry
Biotechnology

Kamada Ltd. engages in the development and production of pharmaceutical products. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

KMDA Intrinsic Value
5.34 USD
Overvaluation 26%
Intrinsic Value
Price
Back to Top